Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Bron
Clinical trial register · France

Clinical Trials in Bron, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9731 matching records held by the registry are in this view. Synced 02 Nov 2026, 03:18 UTC
9731
Studies in scope
all four open statuses
6052
Recruiting now
open to new participants
1028
Lead sponsors
across recruiting studies
Top sites
Paris 68 Marseille 36 Bordeaux 35 Montpellier 32 Lille 31
Narrow the registerReset
Recruitment status
Phase
Site location
Paris68 Marseille36 Bordeaux35 Montpellier32 Lille31
All 73 locations
Target enrolment
to

Trials with a site in Bron

15 of 9731 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Recruiting
Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN
NCT07498335Berger Disease, Bergers Disease, IgA Nephropathy, Immunoglobulin A Nephropathy
Novartis Pharmaceuticals
Phase 3
28
Bron, Nantes, Toulouse
2026-08-06
Active, closed
Rollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other Study Treatments
NCT07468071Locally Advanced or Metastatic KRAS G12C-mutated Non-small Cell Lung Cancer, Advanced Solid Tumors Harboring the KRAS G12C Mutation
Novartis Pharmaceuticals
Phase 1/2
25
Bron, Saint-Herblain, Villejuif
2026-06-08
Active, closed
Novartis Pharmaceuticals
Phase 3
5,700
Bron, Chambray-lès-Tours, Compiègne, Grenoble, Le Coudray, Nantes, Paris, Toulouse
2026-05-11
Recruiting
Novartis Pharmaceuticals
Phase 2
30
Bordeaux, Bron, Le Kremlin-Bicêtre, Lille, Paris
2025-11-03
Recruiting
Novartis Pharmaceuticals
Phase 2
140
Angers, Bron, Dijon, Montpellier, Paris, Toulouse, Tours
2025-10-09
Recruiting
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
NCT06784752Somatostatin Receptor Positive (SSTR+), Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
Novartis Pharmaceuticals
Phase 3
240
Bron, Clichy, Montpellier, Nantes, Pessac, Toulouse
2025-05-30
Active, closed
Novartis Pharmaceuticals
Phase 2
251
Bron, Lille, Nice, Paris, Tours
2024-10-17
Recruiting
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
NCT06562192Pancreatic Ductal Adenocarcinoma, Non-small Cell Lung Cancer, HR+/HER2- Ductal and Lobular Breast Cancer, Triple Negative Breast Cancer
Novartis Pharmaceuticals
Phase 1
162
Bron, Villejuif
2024-10-15
Recruiting
Novartis Pharmaceuticals
Phase 3
450
Saint-Cloud, Bordeaux, Bron, Clermont-Ferrand, Rouen, Saint-Herblain
2024-03-12
Recruiting
Novartis Pharmaceuticals
Phase 2/3
232
Angers, Bordeaux, Bron, Caen, Dijon, Lille, Marseille, Montpellier
2023-11-24
Active, closed
Novartis Pharmaceuticals
Phase 3
20
Bron, Garches, Strasbourg, Toulouse
2022-12-19
Active, closed
Novartis Pharmaceuticals
Phase 2
95
Marseille, Bron, Montpellier, Saint-Herblain, Strasbourg
2022-12-06
Active, closed
Novartis Pharmaceuticals
Phase 3
206
Amiens, Bron, Lille, Marseille, Strasbourg
2017-08-23
Rows per page Showing 1–15 of 15
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 2 November 2026. https://priyalifescience.com/clinical-trials-france/city/bron

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,731 studies in total at the last sync on 02 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 15 of those studies with a site in Bron that also match the filters currently applied.

How many clinical trials are recruiting in Bron?

7 of the 15 studies on this page are recruiting new participants as of the 02 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 8 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Bron), 15 studies
PhaseStudiesRecruitingShare
Phase 36340%
Phase 24226.7%
Phase 12113.3%
Phase 1/22013.3%
Phase 2/3116.7%

Most active sponsors

Lead sponsors with the most studies (Bron)
Lead sponsorStudiesRecruiting
Novartis Pharmaceuticals157
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.